RESUMEN
As células glandulares atípicas representam 0,2% a 2,1% dos resultados dos testes de Papanicolaou. Mesmo com essa baixa prevalência, tem um significado importante no diagnóstico do câncer cervical e endometrial, tendo em vista que tais células e subcategorias, associadas à idade da paciente, podem prenunciar um número expressivo de doença intraepitelial, doença invasiva do endocérvix, endométrio e até neoplasias anexiais. E não se pode esquecer do importante número de resultados histológicos benignos, identificados no seguimento dessas pacientes, muitas vezes assintomáticas.(AU)
Atypical glandular cells represent 0,2% to 2,1% of Pap test results even with this low prevalence has an important significance in the diagnosis of cervical and endometrial cancer, considering that such cells and subcategories associated with the patient's age can predict a significant number of intraepithelial disease, invasive disease of the endometrium, endocervix and even adnexial neoplasms; no forgetting the important number of benign histological results, identified in the follow up of these patients, often asymptomatic.(AU)
Asunto(s)
Humanos , Femenino , Neoplasias del Cuello Uterino/patología , Cuello del Útero/cirugía , Carcinoma Endometrioide/patología , Conización , Adenocarcinoma in Situ/cirugía , Adenocarcinoma in Situ/patología , Colposcopía , Citodiagnóstico/métodosRESUMEN
O adenocarcinoma cervical in situ é uma doença rara, totalmente curável, diagnosticada predominantemente por meio de rastreamento cervicouterino seguido de biópsia guiada por colposcopia e/ou conização. O tratamento em pacientes que desejam preservar a fertilidade pode ser realizado num contexto ambulatorial; aquelas com paridade definida deverão ser abordadas em nível terciário.(AU)
Cervical adenocarcinoma in situ is a rare, fully curable disease diagnosed predominantly through cervical-uterine screening followed by colposcopy-guided biopsy and/or conization. Treatment in patients wishing to preserve fertility may be performed in an outpatient setting; those with defined parity should be approached at the tertiary level.(AU)
Asunto(s)
Humanos , Femenino , Atención Primaria de Salud , Atención Secundaria de Salud , Neoplasias del Cuello Uterino , Adenocarcinoma in Situ , Lesiones Intraepiteliales Escamosas de Cuello Uterino , Cuello del Útero/fisiopatología , ColposcopíaRESUMEN
O adenocarcinoma cervical é uma patologia grave cuja incidência tem aumentado, principalmente em pacientes jovens. Um diagnóstico oportuno, na assistência primária e secundária à saúde, com métodos convencionais, melhora sobremaneira o prognóstico da paciente, a um custo tolerável para países em desenvolvimento.(AU)
The cervical adenocarcinoma is a serious pathology whose incident has increased mainly in young patients. One opportunistic diagnosis, in primary and secondary health care, with conventional methods, greatly improves the prognosis of the patients, at a cost tolerable to developing countries.(AU)
Asunto(s)
Humanos , Femenino , Atención Primaria de Salud , Atención Secundaria de Salud , Adenocarcinoma/clasificación , Neoplasias del Cuello Uterino/diagnóstico , Colposcopía , Adenocarcinoma in Situ/diagnóstico , Diagnóstico Clínico , Factores de Riesgo , Técnicas y Procedimientos Diagnósticos , Células Escamosas Atípicas del Cuello del Útero/patologíaRESUMEN
Objective To investigate the expression of stratum corneum chymotuptic enzyme (SCCE) and its significance in human cervical adenocarcinoma.Methods Immunohistochemistry was used to detect the expressions of SCCE,ER,CEA and Vimentin in tissues from the group of 45 cervical adenocarcinoma patients,group of 24 cervical glandular intraepithelial neoplasia (CGIN) patients and group of 24 normal cervical tissues.Results The expression of SCCE was 84.44 % (38/45),58.33 % (14/24) and 8.33 % (2/24) in 3 groups respectively.The SCCE expression from group of cervical adenocarcinoma were more significantly than that of normal cervical tissues (P < 0.012 5),the expression of SCCE from group of CGIN were more significantly than that of normal cervical tissues (P < 0.012 5),but there was no difference between the cervical adenocarcinoma and the CGIN on the expression of SCCE (P > 0.012 5).Conclusion SCCE could be recommended as a new biomarker for the early screening cervical adenocarcinoma and as an additional marker for the prognosis of cervical adenocarcinoma.